.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The potential link regarding the bovine leukemia virus breast cancer relationship remains a subject of significant scientific investigation. Researchers recently conducted a cross-sectional study at Ankara Etlik City Hospital to evaluate BLV IgG seroprevalence in women. Specifically, the study included 124 participants to compare those with malignant breast cancer against a control group with benign breast lesions. While BLV is a zoonotic retrovirus primarily affecting cattle, its presence in human samples suggests potential cross-species transmission routes that require careful monitoring.
During the study, clinical teams analyzed serum samples from 82 women with confirmed breast cancer and 42 women with benign lesions. Notably, the overall BLV IgG seroprevalence among all participants was 12.9%. Within the malignant group, the seropositivity rate was 13.4%, whereas the benign group showed a rate of 11.9%. Statistical analysis revealed no significant difference between these two groups. However, researchers observed that seropositive patients in the malignant group were significantly older than their seronegative counterparts. This finding indicates that exposure risk might accumulate over time or vary with age-related factors.
Furthermore, international literature presents varying data on this zoonotic threat. Some meta-analyses suggest a higher prevalence of BLV DNA in cancerous breast tissues compared to healthy samples. Moreover, experts identify the consumption of unpasteurized dairy and undercooked meat as primary transmission sources. Nevertheless, the results of this specific Turkish cohort do not support a direct association between BLV seropositivity and malignancy. Consequently, clinicians should consider regional dietary habits and viral prevalence in local cattle when assessing potential risks. Therefore, while the virus is detectable in the human population, its definitive role in carcinogenesis continues to be debated globally.
Humans typically encounter the bovine leukemia virus through the consumption of raw, unpasteurized milk or undercooked meat products derived from infected cattle. Additionally, researchers are investigating other potential environmental and direct contact routes.
No, a positive BLV IgG antibody test only indicates that an individual has been exposed to the virus at some point. Currently, evidence does not confirm that this exposure leads directly to the development of breast cancer.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional diagnosis. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Kürkçü MF et al. Bovine Leukemia Virus Prevalence in Women with Breast Cancer and Premalignant Breast Lesions. Viral Immunol. 2026 Apr 23. doi: 10.1177/08828245261445779. PMID: 42024437.
2. Blanco R et al. Bovine Leukemia Virus and Human Breast Cancer: A Review of Clinical and Molecular Evidence. Viruses. 2025 Feb 26;17(3):324.
3. Saeedi-Moghaddam S et al. Bovine leukemia virus (BLV) and risk of breast cancer; a systematic review and meta-analysis. Infect Agent Cancer. 2024 Dec 03;19(1):45.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study evaluates BLV IgG seroprevalence in 124 women, finding no significant difference between malignant breast cancer and benign lesion groups....
4 months ago
A new case study illuminates how functional connectivity changes drive recovery from pure alexia following posterior cerebral artery infarction. Functional reorganization supports reading recovery despite permanent structural tract disconnection, highlighting key implications for stroke rehabilitation.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
